Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama

Epilepsia

Volumn 44, Issue 6, 2003, Pages 841-846

  Burneo, Jorge G ^a   Arnold, Thomas ^b   Palmer, Cheryl A ^c   Kuzniecky, Ruben I ^a   Oh, Shin J ^d   Faught, Edward ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SEMMES MURPHEY NEUROLOGIC AND SPINE INSTITUTE   (United States)

^c University of Alabama at Birmingham   (United States)

^d The University of Alabama at Birmingham   (United States)

Author keywords

Autosomal dominant; Epilepsy; Kufs disease; Myoclonus; Neuronal ceroid lipofuscinosis; Zonisamide

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; GENETIC RISK; GRAND MAL EPILEPSY; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MYOCLONUS EPILEPSY; NEUROLOGIC EXAMINATION; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE OF ONSET; ALABAMA; BIOPSY; BRAIN; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; EPILEPSY, TONIC-CLONIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUSCLE, SKELETAL; NEURONAL CEROID-LIPOFUSCINOSES; NEURONS; PEDIGREE; SKIN;

EID: 0038644457     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.39802.x     Document Type: Article

References (20)

1. Nardocci N, Verga Luisa M, Binelli S, et al. Neuronal ceroid-lipofuscinosis: a clinical and morphological study of 19 patients. Am J Med Genet 1995;57:137-41.
2. Carpenter S, Karpati G, Andermann F, et al. The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs' disease. Brain 1977;100:137-56.
3. Siakatus AH. Neuronal ceroid lipofuscinosis. In: Myrianthopoulos NC, ed. Handbook of clinical neurology, neurogenetic directory: Part I. Amsterdam: Elsevier/North-Holland Biomedical Press, 1981;42:461-8.
4. Boehme DH, Cottrell JC, Leonberg SC, et al. A dominant form of neuronal ceroid-lipofuscinosis. Brain 1971;94:74-60.
5. Ferrer I, Arbizu T, Peña J, et al. A golgi and ultrastructural study of a dominant form of Kufs' disease. J Neurol 1980;222:183-90.
6. Kravis-Berry E, Sleat DE, Sohar I, et al. Prenatal testing for late infantile neuronal ceroid lipofuscinosis. Ann Neurol 2000;47:254-7.
7. Delgado-Escueta AV, Ganesh S, Yamakawa K. Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 2001;106:129-38.
8. Berkovic SF, Carpenter S, Andermann F, et al. Kufs' disease: a critical reappraisal. Brain 1988;111:27-62.
9. Josephson SA, Schmidt RE, Millsap P, et al. Autosomal dominant Kufs' disease: a cause of early onset dementia. J Neurol Sci 2001;188:51-60.
10. Rider JA, Dawson G, Siakotos AN. Perspective of biochemical research in the neuronal ceroid-lipofuscinosis. Am J Med Genet 1992;42:519-24.
11. Wisniewski KE, Kida E, Patxot OF, et al. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinosis: review of data and observations. Am J Med Genet 1992;42:525-32.
12. Arpa GJ, Gutierrez MM, Barreiro TP, et al. El tipo dominante de ceroide lipofuscinosis del adulto. Soc Español Neurol XXX. Ann Meet Proc 1978.
13. Wolfe LS, Palo J, Santavvori P, et al. Urinary sediment dolichols in the diagnosis of neuronal ceroid-lipofuscinosis. Ann Neurol 1986;19:270-4.
14. Wisniewski KE, Zhong N, Philippart M. Pheno/genotypic correlations of neuronal ceroid lipofuscinosis. Neurology 2001;57:576-81.
15. Wisniewski KE, Kida E, Golabek AA, et al. Neuronal ceroid lipofuscinosis: classification and diagnosis. Adv Genet 2001;45:1-34.
16. Mitchell WA, Wheeler RB, Sharp JD, et al. Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8. Eur J Paediatr Neurol 2001;5(suppl A):121-5.
17. van Diggelen OP, Thobois S, Tilikete C, et al. Adult neuronal ceroid lipofuscinosis with palmitoyl-protein deficiency: first adult-onset patients of a childhood disease. Ann Neurol 2001;50:269-72.
18. Iiranainen M, Himberg J. Valproate and clonazepam in the treatment of severe progressive, myoclonus epilepsy. Arch Neurol 1982;39:236-8.
19. Kyllerman M, Ben-Menachem E. Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Res 1998;29:109-14.
20. Nijssen PCG, Brusse E, Leyfen ACM, et al. Autosomal dominant adult neuronal ceroid lipofuscinosis: parkinsonism due to both striatal and nigral dysfunction. Mov Disord 2002;17:482-7.